North America

Leica Biosystems Unveils High-Speed Aperio GT Elite for Next-Gen Pathology Research

The Aperio GT Elite scanner establishes a new benchmark for high-throughput digital pathology research workflows...

SkinCure Oncology Introduces FDA-Cleared GentleBeam

This Photosonic technology enables a more precise definition of treatment areas...

JenaValve Announces FDA Approval of Trilogy Transcatheter Heart Valve System

Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option...

Trinity Biotech Announces Collaboration with University at Buffalo to Commercialise Novel Biomarkers for Sjögren’s Syndrome

This collaboration is a key strategic milestone in the continued expansion of Trinity Biotech’s New York State Department of Health ...

BrioHealth Celebrates 100th BrioVAD System Implant Milestone

Innovative Investigational Ventricular Assist Device Marks Major Step Forward in Patient Care...

Vieworks to Debut VISQUE DPS LH210 at USCAP 2026

High-throughput, mid-capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimised data size, and scalable digital pathology workflow...

Broad AD/PD 2026 Validation Reinforces ALZpath pTau217 Antibody as Industry Benchmark for Blood-Based Alzheimer’s Diagnosis

Data Across 29 Presentations Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing ALZpath’s Proprietary pTau217 as a Highly Accurate Industry Benchmark...

LifeMD Appoints Atul Kavthekar as Chief Financial Officer

Kavthekar is a seasoned financial executive with nearly three decades of leadership experience spanning provider-side healthcare, retail and speciality pharmacy, e-commerce, and technology...

Luraco Medical Massage Chairs Officially Licensed and Accredited as Durable Medical Equipment

Luraco's medical massage chairs are now positioned to serve a growing role in hospitals, clinical wellness programs...

Amydis Receives Phase 2 NIH Grant Award to Advance a Novel Approach to Detect Biomarker TDP-43

Approximately 97 per cent of people diagnosed with ALS have TDP-43 pathology, making it a central biological hallmark of the disease...